AJAY SHESHADRI to Immunotherapy
This is a "connection" page, showing publications AJAY SHESHADRI has written about Immunotherapy.
Connection Strength
0.977
-
Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2020; 1244:255-269.
Score: 0.262
-
Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2018; 995:131-149.
Score: 0.228
-
Drug-induced Lung Disease in the Oncology Patient: From Cytotoxic Agents to Immunotherapy. Clin Chest Med. 2024 Jun; 45(2):325-337.
Score: 0.088
-
Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease. Curr Opin Pulm Med. 2023 07 01; 29(4):248-255.
Score: 0.083
-
Pulmonary Toxicities of Immunotherapy. Adv Exp Med Biol. 2021; 1342:357-375.
Score: 0.070
-
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer. 2020 10; 8(2).
Score: 0.069
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.057
-
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs. 2018 08; 36(4):601-607.
Score: 0.056
-
Toxicity in the era of immune checkpoint inhibitor therapy. Front Immunol. 2024; 15:1447021.
Score: 0.023
-
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma. Radiother Oncol. 2024 04; 193:110121.
Score: 0.022
-
Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non-Small Cell Lung Cancer. Radiographics. 2022 Nov-Dec; 42(7):1956-1974.
Score: 0.020